Prabhas Cancels Japan Promotional Tour for 'Kalki 2898 AD' Due to Injury

Team Finance Saathi

16/Dec/2024

What's covered under the Article:

Prabhas cancels his promotional visit to Japan for 'Kalki 2898 AD' due to an ankle injury.
Director Nag Ashwin to represent the film at the Japan premiere.
Fans express concern and support, with Prabhas apologizing for his absence.

Prabhas, the beloved actor of Indian cinema, has been forced to cancel his promotional visit to Japan for his upcoming film 'Kalki 2898 AD'. The cancellation follows an ankle injury he sustained while filming. The visit, which was scheduled for December 18, 2024, was highly anticipated by fans in Japan, as it was set to mark the first promotional event for the film in the country.

In response to the unfortunate turn of events, Director Nag Ashwin has stepped in to represent the film at the premiere and promotional activities. The filmmaker will continue the promotional efforts in Prabhas’s absence, ensuring that the event proceeds as planned.

Fans, particularly in Japan, expressed disappointment over Prabhas’s inability to attend the event, but their messages have been overwhelmingly supportive. The actor took to social media to apologize to his fans in Japan, expressing his regret and assuring them that he would make every effort to visit in the future once he fully recovers. His fans have flooded social media with well-wishes, hoping for a swift and smooth recovery, underscoring his vast international fanbase and the strong connection he shares with his followers.

While Prabhas's absence is a setback, the movie continues to generate significant excitement globally, with 'Kalki 2898 AD' being one of the most anticipated films in the Indian film industry. Fans eagerly await its release, confident that the actor's upcoming projects will showcase his remarkable talent once he's back to full health.

The Upcoming IPOs in this week and coming weeks are NACDAC Infrastructure, Transrail Lighting, Mamata Machinery, Identical Brain Studios, Rosmerta Digital, Indo Farm, DAM Capital and Avanse Financial.

The Current active IPO is and International Gemmological, Hamps Bio, Yash Highvoltage and Inventurus Knowledge.

For more details on upcoming IPOs, you can visit our page at Best IPO to Apply Now - IPO List 2024, Latest IPO, Upcoming IPO, Recent IPO News, Live IPO GMP Today - Finance Saathi and stay updated with the latest news on IPO updates on Top News Headlines - Share Market News, Latest IPO News, Business News, Economy News - Finance Saathi. Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates. Start your Stock Market Journey and Apply in IPO by opening a Free Demat Account in Choice Broking FinX.

Disclaimer

The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.

Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.

We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.

You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.

By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.

Services

Prabhas Cancels Japan Promotional Tour for 'Kalki 2898 AD' Due to Injury

Related News

Disclaimer